DNQX
Jump to navigation
Jump to search
| Names | |
|---|---|
| IUPAC name
6,7-Dinitroquinoxaline-2,3(1H,4H)-dione
| |
| Identifiers | |
3D model (JSmol)
|
|
| ChEMBL | |
| DrugBank | |
| |
| |
| Properties | |
| C8H4N4O6 | |
| Molar mass | 252.14 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
| Infobox references | |
DNQX (6,7-dinitroquinoxaline-2,3-dione) is a competitive antagonist at AMPA and kainate receptors, two ionotropic glutamate receptor (iGluR) subfamilies.[1] It is used in a variety of molecular biology subfields, notably neurophysiology, to assist researchers in determining the properties of various types of ion channels and their potential applications in medicine.
See also[edit]
References[edit]
- ^ Traynelis SF, Wollmuth LP, McBain CJ, Menniti FS, Vance KM, Ogden KK, Hansen KB, Yuan H, Myers SJ, Dingledine R (September 2010). "Glutamate receptor ion channels: structure, regulation, and function". Pharmacological Reviews. 62 (3): 405–96. doi:10.1124/pr.109.002451. PMC 2964903. PMID 20716669.
External links[edit]
| This biochemistry article is a stub. You can help Wikipedia by expanding it. |